Drug Dosing: Geriatric Patients

Aging reduces vital physiological functions including renal plasma flow, glomerular filtration, cardiac output, and breathing capacity by 10-30%. These changes decrease drug clearance and prolong drug half-lives, necessitating dose reductions. Additionally, elderly patients often take multiple medications for concurrent conditions, increasing adverse drug reaction risk and requiring careful dosage adjustment.

Elderly individuals have decreased lean body mass and increased body fat, altering drug distribution patterns. Water-soluble drugs show decreased distribution in this population, while lipid-soluble drugs exhibit increased distribution. These compositional changes directly impact drug concentration at target sites and overall pharmacokinetic behavior in geriatric patients.

Progressive decreases in renal size and function significantly impact drug elimination in geriatric patients. Reduced glomerular filtration and renal plasma flow prolong drug half-lives and reduce clearance of renally excreted medications. This necessitates substantial dose reductions for drugs dependent on renal excretion to prevent drug accumulation and toxicity.

The pharmacodynamic hypothesis suggests that aging alters both the quantity and quality of target drug receptors, leading to modified drug responses. These receptor changes may increase sensitivity to certain medications or reduce efficacy of others. Combined with pharmacokinetic changes, altered receptor function contributes to age-dependent increases in adverse drug reactions and therapeutic variability.

Elderly patients are susceptible to cognitive-related adverse events including confusion, dizziness, delirium, and impaired coordination, especially with central nervous system-active drugs. These effects compromise safety and increase risks of falls, hospitalization, and loss of independence. Poor medication compliance due to cognitive decline and complex drug schedules further complicates therapeutic management in this population.

Elderly individuals often require multiple drug therapies to manage concurrent pathophysiological conditions, significantly increasing drug interaction likelihood. Combined with age-related changes in drug absorption, distribution, metabolism, and excretion, polypharmacy elevates adverse drug reaction risk. This necessitates comprehensive medication management and monitoring to ensure therapeutic safety and efficacy.

Age-related changes in hepatic metabolism impact drug responsiveness and clearance in elderly patients. Reduced hepatic function slows drug metabolism and elimination, potentially causing drug accumulation. Understanding hepatic clearance capacity is essential for adjusting doses of medications heavily dependent on liver metabolism to prevent toxicity and maintain therapeutic efficacy.